Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006

Journal of Medical Virology

Volumn 81, Issue 10, 2009, Pages 1819-1825

  Rota, J S ^a   Turner, J C ^b   Yost Daljev, M K ^c   Freeman, M ^c   Toney, D M ^c   Meisel, E ^c   Williams, N ^a   Sowers, S B ^a   Lowe, L ^a   Rota, P A ^a   Nicolai, L A ^d   Peake, L ^e   Bellini, W J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Division of Consolidated Laboratory Services   (United States)

^d VIRGINIA DEPARTMENT OF HEALTH   (United States)

^e Thomas Jefferson Health District   (United States)

Author keywords

IgG EIA; MMR; Mumps; Vaccine failure

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GENETIC ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MALE; MUMPS; MUMPS VIRUS; NUCLEOTIDE SEQUENCE; PAROTITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TITRIMETRY; UNITED STATES; UNIVERSITY STUDENT; VIRUS CULTURE; VIRUS DETECTION;

ADOLESCENT; ANTIBODIES, VIRAL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MUMPS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; STUDENTS; UNIVERSITIES; VIRGINIA; YOUNG ADULT;

MUMPS VIRUS; RUBELLA;

EID: 69949143414     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21557     Document Type: Article

References (22)

1. Bitsko RH, Cortese MM, Dayan GH, Rota PA, Lowe L, Iversen SC, Bellini WJ. 2008. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 46:1101-1103.
2. Boddicker JD, Rota PA, Kreman T, Wangeman A, Lowe L, Hummel KB, Thompson R, Bellini WJ, Pentella M, Desjardin LE. 2007. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol 45:2902-2908. (Pubitemid 47417333)
3. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. 1994. Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine-induced immunity. J Inf Dis 169:77-82. (Pubitemid 24976896)
4. Buxton J, Craig C, Daly P, Bigham M, Bell A, Fyfe M. 1999. An outbreak of mumps among young adults in Vancouver, British Columbia, associated with "rave" parties. Can J Pub Health 90:160-162.
5. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan GH. 2008. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 46:1172-1180.
6. Cui A, Myers R, Xu W, Jin L. 2009. Analysis of the genetic variability of the mumps SH gene in viruses circulating in the UK between 1996 and 2005. Inf Gen Evol 9:71-80.
7. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, Dayan GH. Long-term persistence of mumps antibody after receipt of 2 measles-mumpsrubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Inf Dis 197: 1662-1668.
8. Dayan GH, Quinlisk P, Parker AA, Barskey AE, Harris ML, Schwartz JMH, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, Clayton J, Kightlinger LK, Dietle EG, Berg J, Kenyon CL, Goldstein ST, Stokley SK, Redd SB, Rota PA, Rota J, Bi D, Roush SW, Bridges CB, Santibanez TA, Parashar U, Bellini WJ, Seward JF. 2008. Recent resurgence of mumpsin the United States. N Engl J Med 358:1580-1589.
9. Erdman DD, Heath JL, Watson JC, Markowitz LE, Bellini WJ. 1993. Immunoglobulin M antibody to measles virus following primary and secondary vaccination and natural virus infection. JMed Virol 41:44-48.
10. Hummel KB, Erdman DD, Heath J, Bellini WJ. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol 30:2874-2880.
11. Jin L, Brown DW, Litton PA, White J. 2004. Genetic diversity ofmumps virus in oral fluid specimens: Application tomumps epidemiological study. J Infect Dis 189:1001-1008. (Pubitemid 38373091)
12. Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, Uchida K, Nakayama T, Song J-W, Kang C, Rota PA, Xu W, Featherstone D. 2005. Proposal for genetic characterization of wild-type mumps strains: Preliminary standardisation of the nomenclature. Arch Virol 150:1903-1909. (Pubitemid 41176643)
13. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. 2008. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine. 26:3601-3607.
14. Mauldin J, Carbone K, Hsu H, Yolken R, Rubin S. 2005. Mumps virus-specific antibody titers from pre-vaccine era sera:Comparison of the plaque reduction neutralization assay and enzyme immunoassays. J Clin Microbiol 43:4847-4851. (Pubitemid 41298292)
15. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, Kikuta H, Togashi T. 1998. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol 5:799-803. (Pubitemid 28519254)
16. Pannuti CS, Morello RJ, de Moraes JC, Curti SP, Afonso AMS, Camargo MCC, de Souza VAUF. 2004. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol 11:119-122.
17. Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, Litton P, Miller E. 2002. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 20:1134-1140. (Pubitemid 34135949)
18. Rager-Zisman B, Bazarsky E, Skibin A, Chamney S, Belmaker I, Shai I, Kordysh E, Griffin DE. 2003. The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children. Vaccine 21:2580-2588. (Pubitemid 36561351)
19. Sanz JC, Mosquera MM, Echvarría JE, Fernández M, Herranz N, Palacios G, Ory F. 2006. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 114:788-794. (Pubitemid 44673232)
20. Sanz-Moreno JC, Limia-Sánchez A, García-Comas L, Mosquera- Gutiérrez MM, Echevarria-Mayo JE, Castellanos-Nadal A, de Ory-Manchón F. 2005. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G. Vaccine 23:4921-4925. (Pubitemid 41242868)
21. Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, Brown D. 2005. Mumps outbreak across England and Wales in 2004: Observational study. BMJ 330:1119-1120. (Pubitemid 40686194)
22. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. 2006. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 175:483-488. (Pubitemid 44492298)